Cancer in Inflammatory Bowel Disease
Inflammatory bowel diseases (IBD), including Crohn disease and ulcerative colitis, are chronic inflammatory conditions of the gastrointestinal tract. Individuals with IBD are at increased risk for several malignancies originating in the intestine, such as colorectal cancer, small bowel adenocarcinoma, intestinal lymphoma, and anal cancer. There are also several extraintestinal malignancies associated with IBD and IBD therapies, including cholangiocarcinoma, skin cancer, hematologic malignancies, genitourinary cancer, cervical cancer, and prostate cancer. The authors summarize the risk of cancer in patients with IBD, diagnosis and management of colorectal neoplasia in IBD, and management of patients with IBD and active or recent cancer.
Source: Gastroenterology Clinics of North America - Category: Gastroenterology Authors: Adam S. Faye, Ariela K. Holmer, Jordan E. Axelrad Source Type: research
More News: Adenocarcinoma | Anal Cancer | Bile Duct Cancer | Cancer | Cancer & Oncology | Cervical Cancer | Cholangiocarcinoma | Colorectal Cancer | Crohn's Disease | Gastroenterology | Hematology | Inflammatory Bowel Disease | Jordan Health | Lymphoma | Middle East Health | Prostate Cancer | Skin | Skin Cancer | Ulcerative Colitis